Search

Search Constraints

You searched for: Issue Volume 32(2022)Supplement 2

Search Results

121. 2022-RA-1145-ESGO Cognitive function performance in gynecological cancer patients admitted to the high dependency unit postoperatively. (20th October 2022)

122. 2022-RA-1149-ESGO Oxaliplatin-based treatments are currently a valid therapeutic option in heavily pretreated ovarian cancer patientswith hypersensitivity reactions (HRs) to carboplatin in the antiangiogenics and PARPi era. (20th October 2022)

123. 2022-RA-1151-ESGO Cognitive function performance in patients undergoing maximal effort cytoreduction surgery for gynecological cancer management. (20th October 2022)

124. 2022-RA-1153-ESGO Thromboprophylaxis in surgically treated gynecological cancer patients with tinzaparin in higher than conventional prophylactic dose: preliminary results from the Song-Tin study. (20th October 2022)

126. 2022-RA-1155-ESGO Feasibility of hand assisted laparoscopic sentinel node biopsy in vulvar cancer using combined radioactive and fluorescence guidance. (20th October 2022)

128. 2022-RA-1157-ESGO Is still possible to treat ovarian cancer in a district general hospital? Considerations from our experience. (20th October 2022)